Biotech/Medical Tech Stock News from Investorideas.com

Friday, January 17, 2025

Healthcare Investors Take Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) to NASDAQ Top Percentage Gainers List

Healthcare Investors Take Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) to NASDAQ Top Percentage Gainers List: Healthcare Investors Take Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) to NASDAQ Top Percentage Gainers List

Thursday, January 16, 2025

Biomedical Stock Biomerica Inc. (NASDAQ: BMRA) Makes NASDAQ TOP Gainer List on UAE Ministry of Health and Prevention Approval

Biomedical Stock Biomerica Inc. (NASDAQ: BMRA) Makes NASDAQ TOP Gainer List on UAE Ministry of Health and Prevention Approval: Biomedical Stock Biomerica Inc. (NASDAQ: BMRA) Makes NASDAQ TOP Gainer List on UAE Ministry of Health and Prevention Approval

Friday, January 10, 2025

IPOs in Tech, Biotech and Mining; (NASDAQ: $HIT), (NASDAQ: $NTCL), (NASDAQ: $TTAN), (NASDAQ: $NAMI), (Nasdaq: $ZSPC), (Nasdaq: $JUNS), (NASDAQ: $AVR), (CSE: $KENY.CN)

IPOs in Tech, Biotech and Mining; (NASDAQ: $HIT), (NASDAQ: $NTCL), (NASDAQ: $TTAN), (NASDAQ: $NAMI), (Nasdaq: $ZSPC), (Nasdaq: $JUNS), (NASDAQ: $AVR), (CSE: $KENY.CN)

January 10, 2025 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the tech, Biotech and Mining sectors.

New companies are all recent IPOs on the Nasdaq, NYSE or CSE exchanges.

New stocks added today: Health In Tech, Inc. (NASDAQ:HIT), NetClass Technology Inc (NASDAQ:NTCL), ServiceTitan, Inc. (NASDAQ:TTAN), Jinxin Technology Holding Co (NASDAQ:NAMI), zSpace, Inc. (Nasdaq:ZSPC), JUPITER NEUROSCIENCES, INC. (Nasdaq:JUNS), Anteris Technologies Global Corp. (NASDAQ:AVR), Makenita Resources Inc. (CSE: KENY).

Read this in full at https://www.investorideas.com/news/2025/main/01101IPOs.asp

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

New Stocks Added to the Tech Directories:

Health In Tech, Inc. (NASDAQ:HIT) is an Insurtech platform company backed by third-party AI technology. We offer a dynamic marketplace designed to create customized healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. By eliminating friction and complexities, HIT enhances value propositions for employers and optimizes underwriting, sales, and service workflows for Managing General Underwriters (MGUs), insurance carriers, licensed brokers, and Third-Party Administrators (TPAs).

NetClass Technology Inc (NASDAQ:NTCL) is a leading B2B smart education specialist with offices in Shanghai, Hong Kong, and Singapore, providing innovative IT solutions to schools, training institutions, corporations, public agencies, and other organizations. Our services include SaaS subscription services and application software development, with solutions spanning teaching and campus management, online teaching, examinations, epidemic prevention, data storage, EDC (Education Credit) blockchain systems, and lecturer evaluation services. Our mission is to deliver reliable, high-quality products that drive sustainable growth for our customers.

ServiceTitan, Inc. (NASDAQ:TTAN) is the software platform that powers trades businesses. The company’s cloud-based, end-to-end solution gives contractors the tools they need to run and grow their business, manage their back office, and provide a stellar customer experience. By bringing an integrated SaaS platform to an industry historically underserved by technology, ServiceTitan is equipping tradespeople with the technology they need to keep the world running.

Jinxin Technology Holding Co (NASDAQ:NAMI) Headquartered in Shanghai, China, Jinxin Technology Holding Company is an innovative digital content service provider in China. Leveraging the powerful digital content generation engine powered by advanced AI/AR/VR/digital human technologies, the Company is committed to offering users high-quality digital content services through both its own platform and the content distribution channels of its strong partners. According to Frost & Sullivan, the Company was the largest digital textbook platform in China in terms of revenue in 2022, with a market share of 12.7%. The Company currently target K-9 students in China, with core expertise in providing them digital and integrated educational contents, and plan to further expand service offerings to provide premium and engaging digital contents to other age groups. The Company collaborates with leading textbook publishers in China and provides digital version of mainstream textbooks used in primary schools and middle schools. The Company's AI-generated content technology enables comprehensive digital contents to deliver an interactive, intelligent and entertaining learning experience. The Company distributes digital contents primarily through (i) its flagship learning app, Namibox, (ii) telecom and broadcast operators and (iii) third-party devices with our contents embedded

zSpace, Inc. (Nasdasq:ZSPC) delivers innovative augmented and virtual reality (AR/VR) experiences for STEM, CTE, and career readiness programs. Used by over 3,500 public school districts, technical centers, community colleges, and universities, zSpace allows students and teachers to experience learning in the classroom that may otherwise be dangerous, impossible, counterproductive, or expensive using traditional techniques. Headquartered in San Jose, California, zSpace holds over 70 patents and our hands-on “learning by doing” solutions have been shown to enhance the learning process and drive higher student test scores, as evidenced by a study on the utility of 3D virtual reality technologies for student knowledge gains published in the Journal of Computer Assisted Learning in 2021.

New Stocks Added to the Biotech Directories:

JUPITER NEUROSCIENCES, INC. (Nasdasq:JUNS) is a clinical-stage pharmaceutical company focused on treating neuroinflammation, with a current focus on CNS disorders and rare diseases. The Company’s platform product, JOTROL™, is an enhanced orally administered resveratrol formulation designed and intended to deliver therapeutically relevant, safe levels of resveratrol. The Company’s pipeline is focused broadly on CNS disorder and includes indications such as Alzheimer’s Disease, Parkinson’s Disease, Mucopolysaccharidoses Type I, Friedreich’s Ataxia, and MELAS.

Anteris Technologies Global Corp. (NASDAQ:AVR) is a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA (a MedTech hub), Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients. Anteris’ lead product, the DurAVR® Transcatheter Heart Valve ("THV"), was designed in partnership with the world’s leading interventional cardiologists and cardiac surgeons to treat aortic stenosis – a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR® THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. DurAVR® THV is made using a single piece of molded ADAPT® tissue, Anteris’ patented anti-calcification tissue technology. ADAPT® tissue, which is FDA-cleared, has been used clinically for over 10 years and distributed for use in over 55,000 patients worldwide. The DurAVR® THV System is comprised of the DurAVR® valve, the ADAPT® tissue, and the balloon-expandable ComASUR® Delivery System.

New Stocks Added to the Mining Directories:

Makenita Resources Inc. (CSE: KENY) is a junior resource exploration company focused on the Hector Silver/Cobalt Project in Ontario Canada.

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

800 665 0411

Tuesday, January 7, 2025

Pharma Stock SciSparc Ltd. (Nasdaq: SPRC) Soars on Psychedelic News

Pharma Stock SciSparc Ltd. (Nasdaq: SPRC) Soars on Psychedelic News: Pharma Stock SciSparc Ltd. (Nasdaq: SPRC) Soars on Psychedelic News

Tuesday, December 31, 2024

Medical Therapeutic Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains as CDC reports possible mutations in bird flu

Medical Therapeutic Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains as CDC reports possible mutations in bird flu

Investorideas.com (www.investorideas.com) a go-to platform for big investing ideas for stock traders, including biotech and medical tech stocks reports on trading and news for Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases.

Aethlon is trading up today on investor speculation of bird flu stocks, currently trading at $0.7500, up 0.0893, gaining 13.6107% on volume of over 2.6 Million shares as of this report.

According to Sciencealert.com today, “The ongoing spread of bird flu in the United States has alarmed experts – not just because of human cases causing severe illness, but also due to troubling new instances of infections in cats.”

“A sample of the virus found in a critically ill patient in the United States has shown signs of mutating to better suit human airways, although there is no indication it has spread beyond that individual, authorities report.”

“Earlier this month, officials announced that an elderly Louisiana patient was in "critical condition" with a severe H5N1 infection. “

On December 20^th, Aethlon Medical, Inc. (NASDAQ: AEMD) provided a statement of its investigational medical device with respect to H5N1 avian influenza "Bird Flu."

Aethlon has recently received a number of inquiries regarding the potential utility of its Hemopurifier device in the treatment of Bird Flu. These inquiries come on the heels of the reporting of isolation of Bird Flu in dairy cows, 60 human cases in eight states including a case of severe infection in Louisiana, and yesterday's declaration of a state of emergency in California.

Paid news dissemination for Aethlon Medical.

Read this news, featuring AEMD in full at https://www.investorideas.com/news/2024/biotech/12311Medical-Therapeutic-Stock-AEMD.asp

The Aethlon Hemopurifier is an investigational extracorporeal medical device designed to remove enveloped viruses and extracellular vesicles from the bloodstream. The device incorporates plasma separation, size exclusion, and affinity binding to a proprietary resin containing the plant lectin Galanthus nivalis agglutinin (GNA) bound to a medical grade diatomaceous earth. Enveloped viruses and extracellular vesicles contain the sugar mannose on their surface, which is the therapeutic target of the GNA.

Aethlon has previously contracted Battelle labs to examine the in vitro removal of influenza viruses including H5N1 by a scaled down version of the Aethlon Hemopurifier. In this experiment, cell culture media was spiked with the H5N1 virus and continuously circulated over the device. Samples were taken periodically to examine viral removal by the device. In this study, a miniature version of the device removed 99% of H5N1 following 6 hours of treatment.

While the Aethlon Hemopurifier has not yet been used to treat patients with severe influenza, including those infected with H5N1, it has been used in 38 patients across 164 distinct treatment sessions, targeting diseases such as hepatitis C, HIV, and in patients critically ill due to COVID-19 and Ebola. The Hemopurifier has a "breakthrough device" designation with the FDA for life-threatening viruses for which there is no effective treatment.

Friday, December 27, 2024

What is causing the spike in Biotech Stock Quantum-Si Incorporated (Nasdaq: QSI)?

What is causing the spike in Biotech Stock Quantum-Si Incorporated (Nasdaq: QSI)?: What is causing the spike in Biotech Stock Quantum-Si Incorporated (Nasdaq: QSI)?

Friday, December 20, 2024

Medical Therapeutic Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains on Hemopurifier Bird Flu Update

Medical Therapeutic Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains on Hemopurifier Bird Flu Update

The stock has had big gains in this morning’s trading session following an update on the company’s Hemopurifier device in the treatment of Bird Flu.

The stock is trading at $0.5761, up 0.1427, gaining 32.7745% on volume of over 55 Million shares as of this report. The stock had a day’s high of $0, 8275.

Today Aethlon provided a statement of its investigational medical device with respect to H5N1 avian influenza "Bird Flu."

Paid News Dissemination of behalf of AEMD.

Read this news, featuring AEMD in full at https://www.investorideas.com/news/2024/biotech/12201AEMD-Hemopurifier-Bird-Flu-Update.asp

Current treatment guidelines from the Center for Disease Control and Prevention (https://www.cdc.gov/bird-flu/hcp/novel-av-treatment-guidance/), for hospitalized patients with suspected Bird Flu (H5N1), are to initiate antiviral therapy as soon as possible with Oseltamivir, with or without combination therapy with Baloxavir. Clinical failures during Oseltamavir therapy due to the development of antiviral resistance have been observed in hospitalized patients with H5N1. This phenomenon raises the possibility that novel treatment strategies may be required. Aethlon Medical will monitor this situation closely and interact with hospitals, the state of California, and the FDA as appropriate if cases mount and currently available treatments are not effective.

Disclaimer

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com